These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 6097272
1. Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers. Witte PU, Metzger H, Eckert HG, Irmisch R. Arzneimittelforschung; 1984; 34(10B):1448-51. PubMed ID: 6097272 [Abstract] [Full Text] [Related]
2. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498). Schölkens BA, Becker RH, Kaiser J. Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268 [Abstract] [Full Text] [Related]
3. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. Unger T, Fleck T, Ganten D, Lang RE, Rettig F. Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269 [Abstract] [Full Text] [Related]
12. The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers. Bussien JP, Nussberger J, Porchet M, Waeber B, Brunner HR, Perisic M, Tansey MJ, Bomm M, Hajdu P. Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):63-9. PubMed ID: 2987705 [Abstract] [Full Text] [Related]
14. Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat. Caspritz G, Alpermann HG, Schleyerbach R. Arzneimittelforschung; 1986 Nov; 36(11):1605-8. PubMed ID: 3028436 [Abstract] [Full Text] [Related]